Subpart A—General Labeling Provisions

1. CFR
2. ›
3. Title 21
4. ›
5. Chapter I
6. ›
7. Part 201
8. ›
9. Subpart A

Sections

Section numbering in the official eCFR can be non-consecutive. Omitted section numbers are not treated here as reserved unless the source explicitly labels them that way.

• 201.1
  § 201.1 Drugs; name and place of business of manufacturer, packer, or distributor.
• 201.2
  § 201.2 Drugs and devices; National Drug Code numbers.
• 201.5
  § 201.5 Drugs; adequate directions for use.
• 201.6
  § 201.6 Drugs; misleading statements.
• 201.10
  § 201.10 Drugs; statement of ingredients.
• 201.15
  § 201.15 Drugs; prominence of required label statements.
• 201.16
  § 201.16 Drugs; Spanish-language version of certain required statements.
• 201.17
  § 201.17 Drugs; location of expiration date.
• 201.18
  § 201.18 Drugs; significance of control numbers.
• 201.19
  § 201.19 Drugs; use of term “infant”.
• 201.20
  § 201.20 Declaration of presence of FD&C Yellow No. 5 and/or FD&C Yellow No. 6 in certain drugs for human use.
• 201.21
  § 201.21 Declaration of presence of phenylalanine as a component of aspartame in over-the-counter and prescription drugs for human use.
• 201.22
  § 201.22 Prescription drugs containing sulfites; required warning statements.
• 201.23
  § 201.23 Required pediatric studies.
• 201.24
  § 201.24 Labeling for systemic antibacterial drug products.
• 201.25
  § 201.25 Bar code label requirements.
• 201.26
  § 201.26 Exceptions or alternatives to labeling requirements for human drug products held by the Strategic National Stockpile.